CD14 and B-cell chronic lymphocytic leukemia: Furthermore, statistical analyses revealed that CD14+HLA-DRlow/− cells were significantly associated with the clinical stage of disease in CLL patients (Fig. 1C), indicating that these cells may participate in the progression of CLL.